Home The Word Brain My Amedeo FAQ Privacy About   

As of October 2023, Amedeo had
12,263 active subscribers


  Free Subscription


1 Am J Med
1 Ann Intern Med
2 BMC Cancer
3 Gastroenterol Hepatol
1 Hepatology
1 J Clin Microbiol
2 J Hepatol
3 J Med Virol
1 J Viral Hepat
3 PLoS One
1 Proc Natl Acad Sci U S A

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Med

  1. MALDEN DE, Wong RJ, Chitnis AS, Im TM, et al
    Screening Practices and Risk Factors for Co-Infection with Latent Tuberculosis and Hepatitis B Virus in an Integrated Healthcare System - California, 2008-2019.
    Am J Med. 2023 Nov 22:S0002-9343(23)00707-6. doi: 10.1016/j.amjmed.2023.
    PubMed         Abstract available

    Ann Intern Med

  2. DESAI NM, Leung SG, Motter JD, Segev DL, et al
    Two-Week Direct-Acting Antiviral Prophylaxis for Kidney Transplantation From Donors With Hepatitis C Viremia to Recipients Without Hepatitis C Viremia: A Small Uncontrolled Trial.
    Ann Intern Med. 2023 Nov 28. doi: 10.7326/M23-2682.

    BMC Cancer

  3. ZHANG Y, Lao W, Yang K, Kong X, et al
    SUV39H1 is a novel biomarker targeting oxidative phosphorylation in hepatitis B virus-associated hepatocellular carcinoma.
    BMC Cancer. 2023;23:1159.
    PubMed         Abstract available

  4. ZOU Y, Yue M, Jia L, Wang Y, et al
    Accurate prediction of HCC risk after SVR in patients with hepatitis C cirrhosis based on longitudinal data.
    BMC Cancer. 2023;23:1147.
    PubMed         Abstract available

    Gastroenterol Hepatol

  5. CONTHE A, Ahumada A, Gallego Duran R, Marti-Aguado D, et al
    Current dilemmas in hepatitis virus C management. What should we do after achieving sustained virologic response?
    Gastroenterol Hepatol. 2023;46:826-829.

  6. RIVEIRO-BARCIELA M, Roade L, Martinez-Camprecios J, Vidal-Gonzalez J, et al
    mTOR inhibitors a potential predisposing factor for chronic hepatitis E: Results from the prospective collaborative CHES study (Chronic Hepatitis EScreening in patients with immune impairment and increased transaminases levels).
    Gastroenterol Hepatol. 2023;46:764-773.
    PubMed         Abstract available

  7. ARZALLUS T, Izagirre A, Castiella A, Torrente S, et al
    Drug induced autoimmune hepatitis after turmeric intake.
    Gastroenterol Hepatol. 2023;46:805-806.


  8. SHEN J, Zhang K, Liu M, Wang T, et al
    Letter to the Editor: Alcohol-induced extracellular ASC specks perpetuate liver inflammation and damage in alcohol-associated hepatitis even after alcohol cessation.
    Hepatology. 2023 Nov 28. doi: 10.1097/HEP.0000000000000682.

    J Clin Microbiol

  9. CHEN Z, Li G, Situ J, Li Z, et al
    Redeveloping antigen detection kits for the diagnosis of rat hepatitis E virus.
    J Clin Microbiol. 2023 Dec 1:e0071023. doi: 10.1128/jcm.00710.
    PubMed         Abstract available

    J Hepatol

  10. The adjusted prevalence of hepatitis delta virus (HDV) in 25 countries and territories.
    J Hepatol. 2023 Nov 27:S0168-8278(23)05285-6. doi: 10.1016/j.jhep.2023.
    PubMed         Abstract available

  11. COLASANTI O, Burm R, Huang HE, Riedl T, et al
    Corrigendum to "Comparison of HAV and HCV infections in vivo and in vitro reveals distinct patterns of innate immune evasion and activation" [J Hepatol (2023) 645-656].
    J Hepatol. 2023 Nov 30:S0168-8278(23)05282-0. doi: 10.1016/j.jhep.2023.

    J Med Virol

  12. PI Y, Li Y, Yan Q, Luo H, et al
    SPOP inhibits HBV transcription and replication by ubiquitination and degradation of HNF1alpha.
    J Med Virol. 2023;95:e29254.
    PubMed         Abstract available

  13. WANG C, Zhang S, Zhao J, Wang M, et al
    Changes and gaps of global and regional disease burden of hepatitis B infection in children younger than 5 years old between 2015 and 2019: A real-world data review.
    J Med Virol. 2023;95:e29241.
    PubMed         Abstract available

  14. LIM CK, Romeo O, Tran BM, Flanagan DJ, et al
    Assessment of hepatitis B virus infection and interhost cellular responses using intrahepatic cholangiocyte organoids.
    J Med Virol. 2023;95:e29232.
    PubMed         Abstract available

    J Viral Hepat

  15. O'SULLIVAN M, Jones AM, Mourad A, Haddadin Y, et al
    Excellent hepatitis C virus cure rates despite increasing complexity of people who use drugs: Integrated-Test-stage Treat study final outcomes.
    J Viral Hepat. 2023 Nov 28. doi: 10.1111/jvh.13897.
    PubMed         Abstract available

    PLoS One

  16. PRINSENBERG T, Illidge J, Zantkuijl P, Bedert M, et al
    Correction: Usability, acceptability, and self-reported impact of an innovative hepatitis C risk reduction intervention for men have sex with men: A mixed methods study.
    PLoS One. 2023;18:e0295455.
    PubMed         Abstract available

  17. FONGWEN NT, Nchafack A, Rohan H, Ong JJ, et al
    Role and effectiveness of telephone hotlines in outbreak response in Africa: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0292085.
    PubMed         Abstract available

  18. QI M, Santos H, Pinheiro P, McGuinness DL, et al
    Demographic and socioeconomic determinants of access to care: A subgroup disparity analysis using new equity-focused measurements.
    PLoS One. 2023;18:e0290692.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  19. XIA Y, Cheng X, Nilsson T, Zhang M, et al
    Nucleolin binds to and regulates transcription of hepatitis B virus covalently closed circular DNA minichromosome.
    Proc Natl Acad Sci U S A. 2023;120:e2306390120.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge.